SCHEMBL25418976

SCHEMBL25418976

CC(c1ccc(F)cc1)(c1cc(C#N)sc1S(N)(=O)=O)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.38
PTGS2 P35354 6/20 0.38
PTGS1 P23219 4/20 0.38
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
AR P10275 4/20 0.32
CYP2C19 P33261 1/20 0.32
ABCB11 O95342 1/20 0.32
ALB P02768 1/20 0.32
PGR P06401 1/20 0.32
ADRA2C P18825 1/20 0.32
GHSR Q92847 1/20 0.32
RORC P51449 4/20 0.32
NR1I2 O75469 2/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25419381 0.72 SLC22A12 (0.40) HSD11B1PTGS2PTGS1MEN1KMT2A
SCHEMBL25437516 0.68 AR (0.33) HSD11B1PTGS2PTGS1ARRORC
SCHEMBL2907204 0.64 HSD11B1 (0.56) HSD11B1
SCHEMBL2907205 0.64 HSD11B1 (0.56) HSD11B1
SCHEMBL13210299 0.63 HSD11B1 (0.63) HSD11B1
SCHEMBL25699160 0.63 PGR (0.36) ARPGRCA12CA1CA2
SCHEMBL25420324 0.62 CTSL (0.37)
SCHEMBL30504214 0.62 KCNN4 (0.43) HSD11B1MEN1KMT2A
SCHEMBL26430113 0.60 ACHE (0.41) HSD11B1MEN1KMT2ACYP2C19CA1
SCHEMBL28801791 0.59 KCNN4 (0.38) HSD11B1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4436955-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS Lario Therapeutics Limited (GB) 2024-10-02 EP disclosed
WO-2023094830-A1 SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS LARIO THERAPEUTICS LIMITED (GB) 2023-06-01 WO disclosed